Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MARLOWE PLC Director's Dealing 2025

Mar 7, 2025

7777_dirs_2025-03-07_ec13e059-488c-4200-b3bc-0607709045fe.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 8849Z

Marlowe PLC

07 March 2025

7 March 2025

Marlowe plc

Director/PDMR Shareholding

Grant of Share Award

Marlowe plc ("Marlowe", the "Company" or the "Group"), the leader in business-critical services, announces that on 6 March 2025 (the "Grant Date") it granted share options over 49,480 ordinary shares of 50 pence each in the Company to Adam Councell, Chief Financial Officer of the Company, pursuant to the Marlowe plc Incentive Plan (the "Plan") (the "Share Options").

Details of the Marlowe Incentive Plan were set out in the Company's Directors' Remuneration Report within the Company's Annual Report & Accounts for the financial year ended 31 March 2024.

The Share Options shall vest on the second anniversary of the Grant Date, subject to continued employment and the rules of the Plan.

For further information please contact:

Marlowe plc
Lord Ashcroft, Interim Non-Executive Chair www.marloweplc.com
Adam Councell, Chief Financial Officer Tel: +44 (0)20 3813 8498
Benjamin Tucker, Head of Investor Relations & Strategy [email protected]
Cavendish Capital Markets Limited (Nominated Adviser & Broker)
Ben Jeynes Tel: +44 (0)20 7220 0500
George Lawson
FTI Consulting
Nick Hasell

Alex Le May
Tel: +44 (0)20 3727 1340

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associate

a)

Name

Adam Councell

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Grant of Share Options

c)

Price(s) and volume(s)

Price per share Volume
Nil 49,480

d)

Aggregated Information

Volume

Price

n/a

e)

Date of transaction

06 March 2025

f)

Place of transaction

Outside a trading venue

About Marlowe plc

Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHZZGGFVNFGKZM